ESR1 and breast cancer: Elevated mRNA levels in breast cancer of this positive circadian regulator has been significantly associated with shorter relapse-free survival and recently been regarded as a promising marker of tamoxifen resistance in women with estrogen receptor alpha-positive breast tumours [31].